Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand

Published: Wednesday, April 17, 2013
Last Updated: Wednesday, April 17, 2013
Bookmark and Share
Next generation automation solution designed to help labs process tests faster.

Abbott (NYSE: ABT) has announced the global launch of the ACCELERATOR® a3600, a next generation automation solution, to help laboratories address the need to process tests faster while handling increased volume. Advances in technology and automation within the lab have led to more timely results leading to improved patient care. Automation systems include the various instruments, devices, and software algorithms used in laboratories.

"As laboratories around the world face challenges due to staffing shortages, budget constraints, and increased demands, advances in automation technology such as Abbott's ACCELERATOR a3600 can help labs be more efficient and productive," said Brian Blaser, executive vice president, Diagnostics Products, Abbott. "Labs using automation can achieve more than 40 percent greater efficiency, helping them adapt to meet current and future demand, which is particularly important as approximately 70 percent of medical decisions are informed by diagnostic testing." 1,2

The ACCELERATOR a3600 is a laboratory automation track system that can process up to 3,600 samples per hour and handle multiple tube sizes and types simultaneously. By automating routine, manual tasks, this system may help labs reduce error and improve efficiency. Another advantage of the system is a modular design that offers labs the ability to install up to 99 combined analyzers and modules on a single system, which means that labs can address their testing needs today while planning for the future.

The ACCELERATOR a3600 automation solution, developed with Abbott partner Swiss-based Inpeco SA, is available worldwide pending country registration. To learn more about the role diagnostics can play in increasing quality and efficiency in labs, please click here.

Intended Use

The ACCELERATOR a3600 is a modular system designed to automate pre-analytical and post-analytical processing, sample-handling, and processing in the laboratory. The system consolidates multiple analytical instruments into a unified workstation by employing a common sample processing capability. Through communication connections among the automation system, analyzers, and the laboratory information system (LIS) or middleware, the automation software provides workload and sample-order management, as well as instrument operational status monitoring.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company
Abbott Remains on Track for Separation into Two Publicly Traded Global Health Care Companies by End of 2012
Thursday, March 22, 2012
Abbott's STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
FDA will begin implementing the software-based LIMS as part of the agency's initiative to enhance FDA testing laboratories by managing complex processes and analysing the vast amount of information generated.
Thursday, January 19, 2012
Scientific News
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Applying Deep Learning to Drug Discovery
Researchers train deep neural networks to predict the therapeutic use of large number of multiple drugs using gene expression data obtained from high-throughput experiments on human cell lines.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!